Haemorrhage Alleviation With Tranexamic Acid- Intestinal System
Status:
Completed
Trial end date:
2019-07-19
Target enrollment:
Participant gender:
Summary
Severe bleeding in the digestive system is a common symptom of many diseases. Each year,
about 50,000 people end up in British hospitals because of this problem and about 5,000 of
them die. The most common cause of this bleeding is stomach ulcers. In sub-Saharan Africa,
schistosomiasis (parasitic worms) is responsible for about 130,000 deaths from stomach
bleeding each year. From previous research in other bleeding conditions such as surgery and
trauma, we know that a drug called tranexamic acid can reduce bleeding and save lives. We now
want to do the HALT-IT trial to see if giving tranexamic acid can save lives and if there are
any complications in people with severe bleeding from the digestive system.
Phase:
Phase 3
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Global trial which will include about 40 countries and over 200 hospitals Rawalpindi Medical College University of Ibadan